American International Group Inc. decreased its position in West Pharmaceutical Services Inc. (NYSE:WST) by 2.0% in the first quarter, Holdings Channel reports. The institutional investor owned 148,050 shares of the medical instruments supplier’s stock after selling 3,030 shares during the quarter. American International Group Inc.’s holdings in West Pharmaceutical Services were worth $16,315,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Financial Gravity Wealth Inc. bought a new stake in West Pharmaceutical Services in the first quarter valued at approximately $25,000. Berman Capital Advisors LLC bought a new stake in West Pharmaceutical Services in the fourth quarter valued at approximately $27,000. Quadrant Capital Group LLC lifted its position in West Pharmaceutical Services by 208.7% in the first quarter. Quadrant Capital Group LLC now owns 318 shares of the medical instruments supplier’s stock valued at $32,000 after purchasing an additional 215 shares during the last quarter. Private Capital Group LLC lifted its position in West Pharmaceutical Services by 44.1% in the first quarter. Private Capital Group LLC now owns 673 shares of the medical instruments supplier’s stock valued at $74,000 after purchasing an additional 206 shares during the last quarter. Finally, Contravisory Investment Management Inc. bought a new stake in West Pharmaceutical Services in the fourth quarter valued at approximately $121,000. Institutional investors own 94.44% of the company’s stock.

Shares of WST stock opened at $116.40 on Thursday. The company has a quick ratio of 2.13, a current ratio of 2.88 and a debt-to-equity ratio of 0.19. West Pharmaceutical Services Inc. has a fifty-two week low of $88.04 and a fifty-two week high of $125.09. The company has a market capitalization of $8.53 billion, a price-to-earnings ratio of 41.42, a P/E/G ratio of 3.58 and a beta of 1.29.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, April 25th. The medical instruments supplier reported $0.74 EPS for the quarter, beating analysts’ consensus estimates of $0.66 by $0.08. The company had revenue of $443.50 million during the quarter, compared to the consensus estimate of $431.00 million. West Pharmaceutical Services had a return on equity of 16.38% and a net margin of 12.53%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.62 earnings per share. On average, equities analysts predict that West Pharmaceutical Services Inc. will post 2.87 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 7th. Investors of record on Wednesday, July 24th will be issued a dividend of $0.15 per share. The ex-dividend date is Tuesday, July 23rd. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.52%. West Pharmaceutical Services’s dividend payout ratio is presently 21.35%.

Several analysts have weighed in on WST shares. Zacks Investment Research downgraded West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Saturday, April 27th. Jefferies Financial Group downgraded West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $122.00 price objective for the company. in a research report on Wednesday, May 1st. Finally, William Blair started coverage on West Pharmaceutical Services in a research report on Tuesday, April 23rd. They issued an “outperform” rating and a $112.16 price objective for the company.

In related news, VP Daniel Malone sold 4,458 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $123.03, for a total transaction of $548,467.74. Following the completion of the transaction, the vice president now owns 33,478 shares in the company, valued at $4,118,798.34. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.70% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://theolympiareport.com/2019/05/16/american-international-group-inc-sells-3030-shares-of-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Article: How to Track your Portfolio in Google Finance

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.